Ultralife Corporation (ULBI) Q3 2025 Earnings Call Transcript
Ultralife Corporation ( ULBI ) Q3 2025 Earnings Call November 18, 2025 8:30 AM EST Company Participants Michael Manna - President, CEO & Director Philip A. Fain - CFO, Treasurer & Corporate Secretary Conference Call Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Presentation Operator Good day, and thank you for standing by.
Ultralife Corporation (ULBI) Q2 2025 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q2 2025 Earnings Conference Call August 7, 2025 12:00 PM ET Company Participants Michael E. Manna - President, CEO & Director Philip A.
Ultralife Loses Place On Index, But Is Rebounding Robustly
Ultralife was removed from the FTSE Russell 3000 Microcap Index due to a share price slump, but fundamentals remain strong, and recovery is underway. Recent earnings show robust revenue and EPS growth, boosted by the Electrochem acquisition and improved productivity, supporting a bullish outlook. The valuation remains attractive, with forecasted EPS growth and a one-year price target of $14.12, representing a significant upside from current levels.
Ultralife: Recharging Growth With Smart Acquisitions
Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook.
Ultralife Corporation (ULBI) Q1 2025 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ET Company Participants Alex Villalta - Investor Relations Mike Manna - President & Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company Justin Mechetti - Sidoti & Company Operator Good day and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2025 Results.
Ultralife Corporation (ULBI) Q4 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q4 2024 Earnings Conference Call April 1, 2025 8:30 AM ET Company Participants Alex Villalta - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2024 Results.
Ultralife Corporation (ULBI) Q3 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Manna - President and Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company John Deysher - Pinnacle Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2024 Results Conference Call.
Ultralife Corporation: A Battery Stock Charging Up For A Comeback
Strong revenue growth since Q1 2022, driven by strong demand for battery and energy products in commercial and defense markets. Institutional investors increased positions in the last quarter, and the valuation ratios are near five-year lows. The company improved its balance sheet by reducing debt and maintaining strong liquidity ratios.
Ultralife Corp (ULBI) Trading 8.55% Higher on Oct 2
Shares of Ultralife Corp (ULBI, Financial) surged 8.55% in mid-day trading on Oct 2. The stock reached an intraday high of $10.05, before settling at $10.03, up from its previous close of $9.24.
Ultralife: I Bought The Dip; Here Comes The Growth
ULBI's share price fell to $7 following a cyber-attack, but has since recovered to $11.50, making a 50% return in 6 months. ULBI's growth in sales revenue is driven by its battery and energy products segment, with a focus on lithium-ion batteries and communication systems. The company's adoption of lean manufacturing techniques, margin improvement, and debt paydown have led to a significant increase in performance and future cash generation, warranting a Strong Buy recommendation with a price target of $35.
Ultralife Corporation (ULBI) Q2 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q2 2024 Results Conference Call July 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and thank you for standing by. Welcome to Ultralife Corporation Second Quarter 2024 Results Conference Call.
Ultralife Corporation Is Attractive Here
Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment.
